HYCANTHONE MESYLATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H24N2O2S.CH4O3S
Molecular Weight	452.587
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CS(O)(=O)=O.CCN(CC)CCNC1=CC=C(CO)C2=C1C(=O)C3=C(S2)C=CC=C3

InChI

InChIKey=LOEQGPPJCCUXEJ-UHFFFAOYSA-N

InChI=1S/C20H24N2O2S.CH4O3S/c1-3-22(4-2)12-11-21-16-10-9-14(13-23)20-18(16)19(24)15-7-5-6-8-17(15)25-20;1-5(2,3)4/h5-10,21,23H,3-4,11-13H2,1-2H3;1H3,(H,2,3,4)

HIDE SMILES / InChI

Molecular Formula	C20H24N2O2S
Molecular Weight	356.482
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	CH4O3S
Molecular Weight	96.106
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone | https://www.ncbi.nlm.nih.gov/pubmed/1720380 | https://www.ncbi.nlm.nih.gov/pubmed/1206768 | https://www.ncbi.nlm.nih.gov/pubmed/8270443 | https://www.ncbi.nlm.nih.gov/pubmed/1190369 | https://www.ncbi.nlm.nih.gov/pubmed/7229816 | https://www.ncbi.nlm.nih.gov/pubmed/21935361

Hycanthone is a thioxanthene derivative of lucanthone with anti-schistosomal activity and potential antineoplastic activity. It was clinically available for the treatment of human schistosomiasis. Anti-helmintic action relies on its ability to inhibit worm monoamine oxidase and cholinesterases. Hycanthone produced immediate side effects such as hepatotoxicity and gastrointestinal disturbances, and was consequently withdrawn. Hycanthone inhibits apurinic endonuclease-1 (APE1) by direct protein binding. Hycanthone was used in the 1980s as antitumor agents, it was pulled out of Phase II trials.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
UniProtKB: Q71SU7 (Carboxylic ester hydrolase) 4 Target ID: UniProtKB: Q71SU7 (Carboxylic ester hydrolase) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1190369 \| https://www.ncbi.nlm.nih.gov/pubmed/7229816	Inhibitor 8297
monoamine oxidase activity 6 Target ID: GO:0097621 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7229816	Inhibitor 8297
DNA-(apurinic or apyrimidinic site) lyase 8 Target ID: CHEMBL5619 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21935361	Inhibitor 8297	80.0 nM [IC50]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Schistosomiasis 32 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1206768	Curative		Withdrawn	Hycanthone Approved Use human schistosomiasis
Cancer 592 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8270443 https://www.ncbi.nlm.nih.gov/pubmed/356976 https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone	Primary		Phase II 1132	Unknown Approved Use Unknown

Sourcing

Vendor/Aggregator	ID	URL
1PlusChem LLC	1P00BIB0	https://www.1pchem.com/search?query=1P00BIB0
Ambeed	A204944	http://www.ambeed.com/search/Search.html?keyword=A204944
AstaTech	C74594	http://astatechinc.com/CPSResult.php?CRNO=C74594
BLD Pharm	BD55249	http://www.bldpharm.com/search/Search.html?keyword=BD55249
BOC Sciences	3105-97-3	http://www.bocsci.com/description.asp?cas=3105-97-3
Chem Scene	CS-4690	http://www.chemscene.com/goproductList/searchProductList?productObj=CS-4690
Fluorochem	541743	http://www.fluorochem.co.uk/Products/Product?code=541743
Hairui	HR138995	http://www.hairuichem.com/en/product/search.do?q=HR138995
KeyOrganics	DS-12960	http://www.keyorganicsinc.com/bionet/catalogsearch/result?q=DS-12960
Lab Network	LN01343044	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN01343044
MedChem Express	HY-B1099	https://www.medchemexpress.com/search.html?q=HY-B1099&ft=&fa=&fp=
MolPort	MolPort-003-665-576	https://www.molport.com/shop/molecule-link/MolPort-003-665-576
MuseChem	I007230	https://www.musechem.com/product/I007230.html
Tetrahedron	TS79357	http://www.thsci.com/search.do?q=TS79357
Toronto Research Chemicals	H674305	https://www.trc-canada.com/product-detail/?CatNum=H674305
eMolecules	33507342	https://orderbb.emolecules.com/search/#?query=33507342
eNovation Chemicals	D114144	https://www.enovationchem.com/Products.asp?SEARCHTEXT=D114144&searchbtn.x=0&searchbtn.y=0
mcule	MCULE-7999395699	https://mcule.com/MCULE-7999395699/

PubMed

Title	Date	PubMed
Prediction of genotoxicity of chemical compounds by statistical learning methods.	2005 Jun	15962942
Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.	2009 Aug 18	19688043
Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.	2009 Jul 14	19597541

Patents

Sample Use Guides

In Vivo Use Guide

Human schistosomiasis: single intramuscular dose (3.0, 2.5, 2.0, 1.5, and 1.0 mg/kg body weight).Unresectable pancreatic cancer: hycanthone was administered 60 mg/m2 intravenously within 2 to 4 hr during each day of the 5-day course of infusions during the first and fifth weeks of radiation therapy.

Route of Administration: Other

In Vitro Use Guide

Hycanthone stimulates motor activity of Schistosoma mansoni at concentrations of 10(-6) to 10(-5) M, and partially blocks the paralytic effects of carbachol and physostigmine.

Substance Class	Chemical Created by `admin` on `Sat Dec 16 05:26:14 GMT 2023` Edited by `admin` on `Sat Dec 16 05:26:14 GMT 2023`
Record UNII	48830NW22A
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

HYCANTHONE MESYLATE

Common Name

English

HYCANTHONE MESYLATE [HSDB]

Common Name

English

HYCANTHONE MONOMETHANESULFONATE

Common Name

English

ETRENOL

Brand Name

English

9H-THIOXANTHEN-9-ONE, 1-((2-(DIETHYLAMINO)ETHYL)AMINO)-4-(HYDROXYMETHYL)-, METHANESULFONATE (1:1)

Systematic Name

English

HYCANTHONE MESYLATE [MI]

Common Name

English

HYCANTHONE MESYLATE [IARC]

Common Name

English

HYCANTHONE METHANESULFONATE

Common Name

English

Code System Code Type Description

ECHA (EC/EINECS)

245-527-9